11/15/2025
We're thrilled to share the success of our presentation at today!
Dr. Routh showcased the power of EPISEEK-MPE, our innovative pleural fluid cfDNA Methylation Assay, which has shown its ability to accurately detect cancer.
It may also add prognostic value. The test was a better predictor of 24-month survival than standard-of-care cytology.